This meta-analysis shows that the risk of first thrombotic event is significantly decreased by low dose aspirin among asymptomatic aPL individuals, patients with systemic lupus erythematosus or obstetrical antiphospholipid syndrome. PubMed, Autoimmun Rev, 2013 Nov 2. pii: S1568-9972(13)00207-3. (Also see: Antiphospholid Syndrome)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.